Last $0.64 USD
Change Today -0.002 / -0.31%
Volume 58.7K
TPI On Other Exchanges
Symbol
Exchange
NYSE Amex
Frankfurt
As of 8:04 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

tianyin pharmaceutical co in (TPI) Snapshot

Open
$0.64
Previous Close
$0.64
Day High
$0.69
Day Low
$0.63
52 Week High
10/22/13 - $1.44
52 Week Low
07/15/13 - $0.53
Market Cap
18.8M
Average Volume 10 Days
49.0K
EPS TTM
$0.18
Shares Outstanding
29.4M
EX-Date
05/11/10
P/E TM
3.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for TIANYIN PHARMACEUTICAL CO IN (TPI)

Related News

No related news articles were found.

tianyin pharmaceutical co in (TPI) Related Businessweek News

No Related Businessweek News Found

tianyin pharmaceutical co in (TPI) Details

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company, researches, manufactures, markets, and sells biopharmaceutical medicines, branded generics, modernized traditional Chinese medicines, and other pharmaceuticals in the People’s Republic of China. It offers a portfolio of 58 products for use in the therapeutic areas of internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, gastroenterology, and orthopedics. The company markets its products through regional distributors, as well as directly to the hospitals, clinics, and pharmacies. Tianyin Pharmaceutical Co., Inc. was founded in 1994 and is headquartered in Chengdu, the People’s Republic of China.

1,200 Employees
Last Reported Date: 09/26/13
Founded in 1994

tianyin pharmaceutical co in (TPI) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $100.0K
Chief Financial Officer, Chief Business & Dev...
Total Annual Compensation: $100.0K
Chief Operating Officer, Chief Advisor of Sal...
Total Annual Compensation: $80.0K
Vice President of Operations
Total Annual Compensation: $80.0K
Vice President of Marketing and Sales
Total Annual Compensation: $80.0K
Compensation as of Fiscal Year 2013.

tianyin pharmaceutical co in (TPI) Key Developments

Tianyin Pharmaceutical Co., Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014; Revised Revenue Guidance for the Full Year of 2014

Tianyin Pharmaceutical Co., Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended March 31, 2014. For the quarter, sales were $8,635,104 against $15,525,694 a year ago. Income from operations was $405,849 against $1,792,801 a year ago. Income before provision for income tax was $350,398 against $1,732,868 a year ago. Net income attributable to the company was $37,512 or $0.00 per basic and diluted share against $1,268,709 or $0.04 per basic and diluted share a year ago. For the nine months, sales were $37,306,818 against $49,100,689 a year ago. Income from operations was $5,034,253 against $6,536,022 a year ago. Income before provision for income tax was $4,864,813 against $6,353,661 a year ago. Net loss was $8,462 against net income of $1,258,487 a year ago. Net income was $3,144,089 against $4,627,470 a year ago. Net income attributable to the company was $3,296,242 or $0.11 per basic and diluted share against $4,674,276 or $0.16 per basic and diluted share a year ago. Net cash provided by operating activities was $4,406,751 against $811,434 a year ago. Based on the impact from the suspension of production and sale of Hugan Tablets and the effect from temporary production interruption and the rippling market effect, the company is revising its 2014 previous revenue forecast of 0% to 5% growth year over year to 20% to 30% year over year reduction mainly due to the further underperformance of its generic segment and the rippling market impact from the Hugan Tablets incident.

Tianyin Pharmaceutical Co., Inc., Q3 2014 Earnings Call, May 15, 2014

Tianyin Pharmaceutical Co., Inc., Q3 2014 Earnings Call, May 15, 2014

Tianyin Pharmaceutical Co., Inc. - Shareholder/Analyst Call

Annual Meeting of Shareholders

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TPI:US $0.64 USD -0.002

TPI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TPI.
View Industry Companies
 

Industry Analysis

TPI

Industry Average

Valuation TPI Industry Range
Price/Earnings 3.6x
Price/Sales 0.3x
Price/Book 0.2x
Price/Cash Flow 3.6x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIANYIN PHARMACEUTICAL CO IN, please visit www.tianyinpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.